MLN0264

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MLN0264, covering 2016-07-25 to 2017-05-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction [Phase 2]